Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials

• Atul Deodhar,
• Philip J Mease,
• Iain B McInnes,
• Xenofon Baraliakos,
• Kurt de Vlam,
• Louis Bessette,
• In-Ho Song,
• Dai Feng,
• Koji Kato,
• Anna Maniccia,
• Patrick Zueger,
• William Tillett,
• Andrew J K Ostor,
• Ralph Lippe,
• Tianming Gao,
• Christopher Saffore

Affiliations

Atul Deodhar

3 Oregon Health & Science University, Portland, Oregon, USA

Philip J Mease

Rheumatology Research Division, Providence St. Joseph Health and University of Washington, Swedish Medical Center, Seattle, Washington, USA

Iain B McInnes

MVLS College Office, University of Glasgow, Glasgow, UK

Xenofon Baraliakos

Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum, Bochum, Germany

Kurt de Vlam

Division of Rheumatology, University Hospitals Leuven, Leuven, Belgium

Louis Bessette

Department of Medicine, Laval University, Quebec City, Quebec, Canada

In-Ho Song

AbbVie Inc, North Chicago, Illinois, USA

Dai Feng

Aff400 grid.417993.10000000122600793Merck & Co., Inc. Kenilworth NJ USA

Koji Kato

Department of Immunology, AbbVie Inc, North Chicago, Illinois, USA

Anna Maniccia

Pfizer Inc, New York, New York, USA

Patrick Zueger

Department of Immunology, AbbVie Inc, North Chicago, Illinois, USA

William Tillett

Department of Rheumatology, Royal National Hospital for Rheumatic Disease, Bath, UK

Andrew J K Ostor

Addenbrooke’s Hosptial, Cambridge, UK

Ralph Lippe

Department of Immunology, AbbVie Deutschland GmbH & Co KG, Wiesbaden, Hesse, Germany

Tianming Gao

AbbVie Inc, North Chicago, Illinois, USA

Christopher Saffore

AbbVie Inc, North Chicago, Illinois, USA